Table 4.
The correlations between LV diastolic function parameters and other clinical parameters in hyperthyroid subjects.
| MVE | MVA | E/A ratio | ||||
|---|---|---|---|---|---|---|
| Rs | P -value | Rs | P -value | Rs | P -value | |
| Age | −0.193 | <0.001 | 0.209 | <0.001 | −0.355 | <0.001 |
| Female | 0.160 | 0.002 | 0.175 | 0.001 | −0.050 | 0.330 |
| BMI | −0.178 | <0.001 | 0.105 | 0.038 | −0.250 | <0.001 |
| SBP | 0.047 | 0.356 | 0.141 | 0.005 | −0.075 | 0.139 |
| DBP | 0.025 | 0.624 | 0.076 | 0.134 | −0.052 | 0.305 |
| HR | 0.068 | 0.184 | 0.180 | <0.001 | −0.098 | 0.054 |
| eGFR | 0.253 | <0.001 | −0.060 | 0.241 | 0.267 | <0.001 |
| SUA | −0.058 | 0.254 | −0.010 | 0.845 | −0.033 | 0.511 |
| Scr | −0.233 | <0.001 | −0.209 | <0.001 | 0.018 | 0.727 |
| Sodium | −0.104 | 0.042 | 0.055 | 0.283 | −0.148 | 0.004 |
| Potassium | 0.032 | 0.530 | −0.065 | 0.204 | 0.085 | 0.093 |
| Calcium | −0.001 | 0.980 | 0.074 | 0.145 | −0.067 | 0.185 |
| Hyperuricemia | −0.065 | 0.200 | 0.026 | 0.605 | −0.083 | 0.103 |
| Hypertension | −0.014 | 0.790 | 0.143 | 0.005 | −0.145 | 0.004 |
| DM | −0.033 | 0.516 | 0.056 | 0.271 | −0.077 | 0.186 |
| FT3 | 0.143 | 0.005 | 0.195 | <0.001 | −0.080 | 0.115 |
| FT4 | 0.179 | <0.001 | 0.201 | <0.001 | −0.052 | 0.308 |
| TSH | −0.039 | 0.447 | −0.155 | 0.002 | 0.122 | 0.016 |
| LAD | 0.125 | 0.014 | 0.233 | <0.001 | −0.124 | 0.014 |
| LVEDD | 0.021 | 0.680 | −0.004 | 0.942 | 0.037 | 0.471 |
| IVST | −0.085 | 0.095 | 0.131 | 0.010 | −0.205 | <0.001 |
| LVEF | 0.091 | 0.073 | 0.087 | 0.088 | −0.009 | 0.856 |
LV, Left ventricular; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; eGFR, estimated glomerular filtration rate; SUA, serum uric acid; Scr, serum creatinine; DM, diabetes mellitus; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; LAD, left atrium diameter; LVEDD, left ventricular end-diastolic diameter; IVST, interventricular septum thickness; LVEF, left ventricular ejection fraction.